Neoadjuvant radiotherapy (N-RT) for intracebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial

被引：0
|
作者：
Diehl, C. [1 ,2 ]
Shiban, E. [3 ]
Straube, C. [1 ,2 ]
Oechsner, M. [1 ]
Kessel, C. [1 ]
Wilkens, J. J. [1 ]
Wiestler, B. [4 ]
Zimmer, C. [4 ]
Meyer, B. [3 ]
Combs, S. E. [1 ,2 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Klin Radioonkol, Munich, Germany
[2] Helmholtz Zentrum Munich, Inst Innovat Radiotherapie iRT, Neuherberg, Germany
[3] Tech Univ Munich, Klin Neurochirurg, Klinikum Rechts Isar, Munich, Germany
[4] Tech Univ Munich, Inst Neuroradiol, Klinikum Rechts Isar, Munich, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2019年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P15-4-jD
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [31] Phase I dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors
    Masters, GA
    Brockstein, BE
    Mani, S
    Ratain, MJ
    MEDICAL ONCOLOGY, 2003, 20 (01) : 7 - 12
  • [32] Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
    Demetri, George D.
    Lo Russo, Patricia
    MacPherson, Lain R. J.
    Wang, Ding
    Morgan, Jeffrey A.
    Brunton, Valerie G.
    Paliwal, Prashni
    Agrawal, Shruti
    Voi, Maurizio
    Evan, T. R. Jeffry
    CLINICAL CANCER RESEARCH, 2009, 15 (19) : 6232 - 6240
  • [33] Phase I dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors
    Gregory A. Masters
    Bruce E. Brockstein
    Sridhar Mani
    Mark J. Ratain
    Medical Oncology, 2003, 20 : 7 - 12
  • [34] A phase I dose escalation study of sunitinib plus capecitabine in patients with advanced solid tumors
    Sweeney, C.
    Verschraegen, C.
    Chiorean, G.
    Lee, F.
    Jones, S.
    Tye, L.
    Bello, A.
    Chao, R.
    Burris, H., III
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] Maximum Tolerated Dose of Neoadjuvant Stereotactic Radiosurgery and Post-Treatment Immune Profiling for Metastatic Brain Tumors: Results of a Phase I Dose Escalation Trial
    Zhang, S. C.
    Yoshida, E. J.
    Diniz, M. A.
    Patil, C. S.
    Yu, J. S.
    Chu, R. M.
    Jang, J. K.
    Anderson, K.
    Hakimian, B.
    Mirhadi, A. J.
    Hu, J. L.
    Rudnick, J.
    Atkins, K. M.
    Shiao, S. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S192 - S193
  • [36] A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors
    de Braud, F.
    Cascinu, S.
    Spitaleri, G.
    Pilz, K.
    Clementi, L.
    Liu, D.
    Sikken, P.
    De Pas, T.
    ANNALS OF ONCOLOGY, 2015, 26 (11) : 2341 - 2346
  • [37] A phase I dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumors
    Sharma, Sunil
    Beck, Joachim
    Mita, Monica
    Paul, Sofia
    Woo, Margaret M.
    Squier, Margaret
    Gadbaw, Brian
    Prince, H. Miles
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (04) : 974 - 985
  • [38] A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors
    Ferrarotto, R.
    Eckhardt, G.
    Patnaik, A.
    LoRusso, P.
    Faoro, L.
    Heymach, J. V.
    Kapoun, A. M.
    Xu, L.
    Munster, P.
    ANNALS OF ONCOLOGY, 2018, 29 (07) : 1561 - 1568
  • [39] A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial)
    Mercier, Carole
    Dirix, Piet
    Meijnders, Paul
    Vermeulen, Peter
    Van Laere, Steven
    Debois, Hilde
    Huget, Philippe
    Verellen, Dirk
    RADIATION ONCOLOGY, 2018, 13
  • [40] A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial)
    Carole Mercier
    Piet Dirix
    Paul Meijnders
    Peter Vermeulen
    Steven Van Laere
    Hilde Debois
    Philippe Huget
    Dirk Verellen
    Radiation Oncology, 13
12345